Global intra-uterine contraceptive devices market is expected to reach USD 4.9 billion by 2024 from USD 3.68 billion in 2013, at a CAGR of 3.5% in the forecast period 2017 to 2024.
Global Intra-Uterine Contraceptive Devices, By Product Type (Hormonal IUCD, Copper IUCD), By End-User (Hospitals, Gynecology Clinics, Community Healthcare), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) –Industry Trends and Forecast to 2024
The Global Intra Uterine Contraceptive Devices market is segmented on the basis of product type, end-user and geography.
Based on geographical segmentation the global nasal spray market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The report of this market covers data for major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa.
Key Players operating in the Global intra-uterine contraceptive devices market:
Global Topical Drug Delivery Market, By Product Type (Topical Drug Delivery Formulations (Solid, Liquid, Semi Solid), Transdermal Drug Delivery Devices (Transdermal Patches, Transdermal Gels)), By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others), By Distribution Channel (Direct Tenders, Retail), By Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World) – Trends and Forecast to 2024
Office Number-317, Amanora Chambers,
Magarpatta Road, Hadapsar,